Thrombopoietin
Top View
- Stable Liver Function During Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease
- Thrombopoietin Receptor Agonists for the Treatment of Inherited
- Fine-Tuning of Hematopoietic Stem Cell Homeostasis: Novel Role for Ubiquitin Ligase
- Human Thrombopoietin Quantikine
- Cytokine Receptors and Hematopoietic Differentiation
- A Phase I Clinical, Pharmacologic, and Biologic Study Of
- Permissive Role of Thrombopoietin and Granulocyte Colony-Stimulating Factor Receptors in Hematopoietic Cell Fate Decisions in Vivo
- Immunoassay Platforms and Products: R&D Systems
- Supplementary Data
- Supplemental Methods
- DOPTELET Is a Thrombopoietin (TPO) Receptor Agonist…
- Antitumoral Activity of Allosteric Inhibitors of Protein Kinase CK2
- Targeting the FMS-Like Tyrosine Kinase 3 in Acute Myeloid Leukemia
- The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
- Thrombopoietin, Human (T1568)
- Thrombopoietin Protects Hematopoietic Stem Cells from Retrotransposon-Mediated Damage by Promoting an Antiviral Response
- Impact of MLL5 Expression on Decitabine Efficacy and DNA Methylation in Acute Myeloid Leukemia
- Cell-Penetrating TAT-FOXO3 Fusion Proteins Induce Apoptotic Cell Death in Leukemic Cells